Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model

European Journal of Pharmacology

Volumn 536, Issue 1-2, 2006, Pages 148-153

  Ashikaga, Keiichi ^a   Kobayashi, Takao ^a   Kimura, Masaomi ^a   Owada, Shingen ^a   Sasaki, Shingo ^a   Iwasa, Atsushi ^a   Furukawa, Ken ichi ^a   Motomura, Shigeru ^a   Okumura, Ken ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Amiodarone; Atrial fibrillation; Electrical remodeling; Matrix metalloproteinase; Structural remodeling

Indexed keywords

AMIODARONE; GELATINASE A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; DRUG EFFECT; ELECTROSURGERY; ENZYME ACTIVITY; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART MUSCLE CONDUCTION SYSTEM; HEART MUSCLE FIBROSIS; HEART MUSCLE POTENTIAL; HEART PACING; HEART RIGHT ATRIUM; HEART VENTRICLE PACING; HEART VENTRICLE REMODELING; NONHUMAN; PRIORITY JOURNAL; SINUS NODE CONDUCTION VELOCITY;

ACTION POTENTIALS; ADMINISTRATION, ORAL; AMIODARONE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; DISEASE MODELS, ANIMAL; DOG DISEASES; DOGS; FIBROSIS; HEART ATRIA; HEART CONDUCTION SYSTEM; HEART VENTRICLES; HUMANS; IMMUNOBLOTTING; MATRIX METALLOPROTEINASE 2; VENTRICULAR REMODELING;

EID: 33645823372     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.02.023     Document Type: Article

References (22)

1. Allessie M.A., Ausma J., and Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc. Res. 54 (2002) 230-246
2. Ausma J., Wijffels M., Thone F., Wouters L., Allessie M., and Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 96 (1997) 3157-3163
3. Boixel C., Fontaine V., Rucker-Martin C., Milliez P., Louedec L., Michel J.B., Jacob M.P., and Hatem S.N. Fibrosis of the left atria during progression of heart failure is associated with increased matrix metalloproteinases in the rat. J. Am. Coll. Cardiol. 42 (2003) 336-344
4. Gaspo R., Bosch R.F., Talajic M., and Nattel S. Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model. Circulation 96 (1997) 4027-4035
5. Grote K., Flach I., Luchtefeld M., Akin E., Holland S.M., Drexler H., and Schieffer B. Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen species. Circ. Res. 92 (2003) 80-86
6. Ide T., Tsutsui H., Kinugawa S., Utsumi H., and Takeshita A. Amiodarone protects cardiac myocytes against oxidative injury by its free radical scavenging action. Circulation 100 (1999) 690-692
7. Kodama I., Kamiya K., and Toyama J. Amiodarone: ionic and cellular mechanisms of action of the most promising class III agent. Am. J. Cardiol. 84 (1999) 20-28
8. Li D., Shinagawa K., Pang L., Leung T.K., Cardin S., Wang Z., and Nattel S. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation 104 (2001) 2608-2614
9. Matsumori A., Ono K., Nishio R., Nose Y., and Sasayama S. Amiodarone inhibits production of tumor necrosis factor-α by human mononuclear cells: a possible mechanism for its effect in heart failure. Circulation 96 (1997) 1386-1389
10. Nakano Y., Niida S., Dote K., Takenaka S., Hirao H., Miura F., Ishida M., Shingu T., Sueda T., Yoshizumi M., and Chayama K. Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation. J. Am. Coll. Cardiol. 43 (2004) 818-825
11. Nakashima H., Kumagai K., Urata H., Gondo N., Ideishi M., and Arakawa K. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation 101 (2000) 2612-2617
12. Nattel S., and Li D. Ionic remodeling in the heart: pathophysiological significance and new therapeutic opportunities for atrial fibrillation. Circ. Res. 87 (2000) 440-447
13. Roy D., Talajic M., Dorian P., Connolly S., Eisenberg M.J., Green M., Kus T., Lambert J., Dubuc M., Gagne P., Nattel S., and Thibault B. Amiodarone to prevent recurrence of atrial fibrillation. N. Engl. J. Med. 342 (2000) 913-920
14. Shinagawa K., Shiroshita-Takeshita A., Schram G., and Nattel S. Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium: insights into the mechanism of the superior efficacy of amiodarone. Circulation 107 (2003) 1440-1446
15. Sicouri S., Moro S., Litovsky S., Elizari M.V., and Antzelevitch C. Chronic amiodarone reduces transmural dispersion of repolarization in the canine heart. J. Cardiovasc. Electrophysiol. 8 (1997) 1269-1279
16. Spinale F.G. Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circ. Res. 90 (2002) 520-530
17. Spinale F.G., Coker M.L., Thomas C.V., Walker J.D., Mukherjee R., and Hebbar L. Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function. Circ. Res. 82 (1998) 482-495
18. Thomas C.V., Coker M.L., Zellner J.L., Handy J.R., Crumbley III A.J., and Spinale F.G. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Circulation 97 (1998) 1708-1715
19. van der Velden H.M.W., van der Zee L., Wijffels M.C., van Leuven C., Dorland R., Vos M.A., Jongsma H.J., and Allessie M.A. Atrial fibrillation in the goat induces changes in monophasic action potential and mRNA expression of ion channels involved in repolarization. J. Cardiovasc. Electrophysiol. 11 (2000) 1262-1269
20. Wijffels M.C., Kirchhof C.J., Dorland R., and Allessie M.A. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 92 (1995) 1954-1968
21. Xu J., Cui G., Esmailian F., Plunkett M., Marelli D., Ardehali A., Odim J., Laks H., and Sen L. Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation. Circulation 109 (2004) 363-368
22. Yue L., Feng J., Gaspo R., Li G.R., Wang Z., and Nattel S. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ. Res. 81 (1997) 512-525